Document is current
Any future updates will be listed below
-
Authors
Naber, Kurt G. http://orcid.org/0000-0003-1304-5403
Wagenlehner, Florian M. E.
- License Information
-
More Information
Article History
First Online: 3 December 2019
Competing interests
: K.G.N declares personal fees from Adamed, Allecra, Apogepha, Aristo, Bionorica, Biomerieux, Enteris, GlaxoSmithKline (GSK), Gruenenthal Mexico, Helperby, Marpinion, MerLion, Medice, Merck Sharp & Dohme (MSD), OM Pharma/Vifor, Paratek, Roche, Saxonia and Zambon and non-financial support from Mission Pharmacal, outside the submitted work. F.M.E.W. declares other fees from Achaogen, Bionorica, OM Pharma/Vifor Pharma and Shionogi, and personal fees from AstraZeneca, Bionorica, Enteris BioPharma, GSK, Janssen, LeoPharma, MerLion, MSD, Pfizer, RosenPharma and VenatoRx, and other from Helperby Therapeutics and Deutsches Zentrum für Infektionsforschung (DZIF; Giessen-Marburg-Langen site), outside the submitted work.
